New Compounds Against Chagas Disease
Author Information
Author(s): Bettiol Esther, Samanovic Marie, Murkin Andrew S., Raper Jayne, Buckner Frederick, Rodriguez Ana
Primary Institution: New York University School of Medicine
Hypothesis
Can a chemical library screening identify new compounds effective against Trypanosoma cruzi?
Conclusion
Three new compounds were identified that effectively inhibit the growth of Trypanosoma cruzi with low toxicity to host cells.
Supporting Evidence
- Three compounds were selected for their high activity against T. cruzi and low toxicity to host cells.
- IC50 values for the compounds were found to be in the low nanomolar range.
- The compounds also showed high activity against related species Leishmania major and L. amazonensis.
Takeaway
Scientists looked through a big box of chemicals to find new medicines that can help fight a disease caused by a tiny bug, and they found three that work really well.
Methodology
A whole cell-based assay was optimized for high throughput screening of a 2000-compound library against Trypanosoma cruzi.
Potential Biases
Potential bias in selecting compounds based on initial toxicity and efficacy screening.
Limitations
The study primarily focused on in vitro results, and further in vivo testing is needed to confirm efficacy and safety.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website